Similarly, suppressing maladaptive antioxidants, rather than interfering with physiological mitochondrial H2O2-mediated signaling, may allow the maintenance of intact hepatic insulin signaling in NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.